Literature DB >> 17566083

GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha.

Stefano Michienzi1, Natasha Cherman, Kenn Holmbeck, Alessia Funari, Michael T Collins, Paolo Bianco, Pamela Gehron Robey, Mara Riminucci.   

Abstract

Activating mutations of the Gsalpha gene, encoded by the guanine nucleotide-binding protein, alpha stimulating (GNAS) locus located on chromosome 20q13, underlie different clinical phenotypes characterized by skeletal lesions [fibrous dysplasia (FD) of bone], extraskeletal diseases (mainly endocrine hyperfunction and skin hyperpigmentation) and variable combinations thereof [the McCune-Albright syndrome (MAS)]. This clinical heterogeneity is commonly assumed to reflect the post-zygotic origin of the mutation. However, the pattern of imprinting of the Gsalpha gene in some human post-natal tissues suggests that parental-dependent epigenetic mechanisms may also play a role in the phenotypic effect of the mutated GNAS genotype. FD lesions are generated by mutated clonogenic osteoprogenitors that reside, along with their normal counterparts, in FD bone marrow stroma. We analyzed the allelic expression pattern of Gsalpha and other GNAS alternative transcripts in the progeny of normal and mutated clonogenic stromal cells isolated in vitro from a series of informative FD/MAS patients. We report here for the first time that the two Gsalpha alleles are unequally expressed in both normal and FD-mutated stromal clones. However, in contrast to imprinting, the ratio of Gsalpha allelic expression is randomly established in different clones from the same patient. This result suggests that a parental-independent modulation of Gsalpha expression occurs in clonogenic osteoprogenitor cells and, at the single cell level, may impact on the severity of an FD lesion. Furthermore, we show that normal and mutated clonogenic stromal cells express GNAS alternative transcripts other than the common Gsalpha, some of which may be relevant to the development of FD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566083     DOI: 10.1093/hmg/ddm139

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

1.  "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease.

Authors:  Paolo Bianco; Pamela Gehron Robey; Isabella Saggio; Mara Riminucci
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

2.  Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia.

Authors:  Dana M Cairns; Robert J Pignolo; Tomoya Uchimura; Tracy A Brennan; Carter M Lindborg; Meiqi Xu; Frederick S Kaplan; Eileen M Shore; Li Zeng
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

3.  A G protein-coupled, IP3/protein kinase C pathway controlling the synthesis of phosphaturic hormone FGF23.

Authors:  Qing He; Lauren T Shumate; Julia Matthias; Cumhur Aydin; Marc N Wein; Jordan M Spatz; Regina Goetz; Moosa Mohammadi; Antonius Plagge; Paola Divieti Pajevic; Murat Bastepe
Journal:  JCI Insight       Date:  2019-09-05

Review 4.  Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.

Authors:  Iris Hartley; Maria Zhadina; Micheal T Collins; Alison M Boyce
Journal:  Calcif Tissue Int       Date:  2019-04-29       Impact factor: 4.333

Review 5.  Inherited human diseases of heterotopic bone formation.

Authors:  Eileen M Shore; Frederick S Kaplan
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

6.  Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.

Authors:  Virginie Mariot; Joy Y Wu; Cumhur Aydin; Giovanna Mantovani; Matthew J Mahon; Agnès Linglart; Murat Bastepe
Journal:  Bone       Date:  2010-09-29       Impact factor: 4.398

7.  Extra-long Gαs variant XLαs protein escapes activation-induced subcellular redistribution and is able to provide sustained signaling.

Authors:  Zun Liu; Serap Turan; Vanessa L Wehbi; Jean-Pierre Vilardaga; Murat Bastepe
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

8.  Extralarge XL(alpha)s (XXL(alpha)s), a variant of stimulatory G protein alpha-subunit (Gs(alpha)), is a distinct, membrane-anchored GNAS product that can mimic Gs(alpha).

Authors:  Cumhur Aydin; Nurgul Aytan; Mathew J Mahon; Hesham A W Tawfeek; Neil W Kowall; Alpaslan Dedeoglu; Murat Bastepe
Journal:  Endocrinology       Date:  2009-05-07       Impact factor: 4.736

Review 9.  GNAS mutations and heterotopic ossification.

Authors:  Murat Bastepe
Journal:  Bone       Date:  2017-09-06       Impact factor: 4.398

Review 10.  Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation.

Authors:  Alison M Boyce; Michael T Collins
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.